Pricing Log in Create free account
Friday 6 November 2026 Export GRAL’s income statement to Excel — free account

GRAIL, Inc.

GRAL Healthcare Diagnostics & Research

GRAIL, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $147.2 million, up 17.2% from fiscal 2024.

Revenue
+3.71%
EPS
+10.2%
Free cash flow
−24.9%

Quarter to September 2026, against a year earlier

124.40 19.26 −13.41%
Market cap
$5.3B
P/E
0.0×
Fwd P/E
−14.5×
Dividend yield
—
F-score
6/9
Altman Z
0.37
Beneish M
n/a
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

GRAIL, Inc. (GRAL) Gross margin

Alert me on Gross margin

GRAIL, Inc.'s gross margin over the twelve months to 30 September 2026 was 0.00%, up 42.5 percentage points from fiscal 2025 (−42.5%). That is below the Diagnostics & Research industry median of 48.3% and below the Healthcare sector median of 53.9%.

Gross margin, annual

Embed this chart

Annual newest first

Period Gross margin Change (points)
FY2025 −42.5% 19.60
FY2024 −62.1% 40.57
FY2023 −102.7% 106.94
FY2022 −209.6% —

Quarterly newest first

Period Gross margin Change (points)
Sep 2026 0.00% 28.12
Jun 2026 −28.1% 6.96
Mar 2026 −35.1% (9.54)
Dec 2025 −25.5% 12.40
9 more quarters

Gross margin against peers

Company Gross margin
ADPT Adaptive Biotechnologies Corporation compare 74.2%
VCYT Veracyte, Inc. compare 72.0%
BLLN BillionToOne, Inc. compare 71.4%
CDNA CareDx, Inc. compare 71.0%
QGEN QIAGEN N.V. compare 62.2%
SHC Sotera Health Company compare 54.6%
ICLR ICON PLC compare 23.4%
RDNT RadNet, Inc. compare 11.5%
GRAL GRAIL, Inc. 0.00%
Diagnostics & Research industry median 48.3%
Healthcare sector median 53.9%
Market median 45.1%

What Gross margin is

Gross Margin tells an investor how much of each sale a company keeps after paying the direct costs of making or buying what it sells.

Gross Profit ÷ Revenue

The full definition of Gross margin →

More on GRAL